chloroquine has been researched along with abt-737 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobromilskaya, I; Gardner, EE; Hann, CL; Marchionni, L; Murphy, S; Rudin, CM; Zinn, RL | 1 |
| Chen, F; Jia, J; Li, J; Song, Y; Yin, P; Zhang, Y | 1 |
2 other study(ies) available for chloroquine and abt-737
| Article | Year |
|---|---|
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Biphenyl Compounds; Cell Proliferation; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Nitrophenols; Piperazines; RNA, Small Interfering; Small Cell Lung Carcinoma; Sulfonamides; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Chloroquine; Drug Synergism; Humans; Kidney Neoplasms; Leucine; Nitrophenols; Oligopeptides; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiadiazoles | 2016 |